post-add

Biocon Ranks Among Top 10 Global Employers, Recognised For Innovation By Science Magazine

Biocon has once again secured a spot in Science magazine's prestigious Top 10 Global Employers list. The company, along with its subsidiary Biocon Biologics, has been ranked No. 9 in the global biotech, pharma, and biopharma sectors, continuing its decade-long recognition as an industry innovator.

Biocon has once again secured a spot in Science magazine's prestigious Top 10 Global Employers list. The company, along with its subsidiary Biocon Biologics, has been ranked No. 9 in the global biotech, pharma, and biopharma sectors, continuing its decade-long recognition as an industry innovator.

This achievement highlights Biocon's commitment to innovation and excellence, with the company consistently making the Science magazine list since 2012. The ranking reflects Biocon's emphasis on research and development, collaboration, and a patient-centric approach. According to a press statement, key attributes that make Biocon stand out include being socially responsible, having a loyal workforce, and maintaining its position as a leading employer brand in biotechnology.

Kiran Mazumdar Shaw, Chairperson of Biocon Group, said, “Biocon has always been R&D-led, fostering a culture of ideation, experimentation, and collaboration, with patients at the core of its business. These attributes have placed us among the Top 10 Global Employers several years in a row. Our people are united by the shared purpose of making affordable, high-quality medicines accessible worldwide.”

As per the press statement, the 2024 rankings are based on a comprehensive web-based survey conducted among approximately 6,400 professionals, with respondents from North America, Europe, and the Asia-Pacific region. Most participants were employed in biotechnology, biopharmaceutical, and pharmaceutical companies, including employees from both Biocon and Biocon Biologics.

Biocon's enduring presence in the Top 10 Global Employers list reflects its aim to innovate and its leadership in the biopharmaceutical sector.

Also Read

Subscribe to our newsletter to get updates on our latest news